KRAS Mutation is Associated with Worse Prognosis in Stage III or High-risk Stage II Colon Cancer Patients Treated with Adjuvant FOLFOX-Reference-Cited by-同舟云学术

KRAS Mutation is Associated with Worse Prognosis in Stage III or High-risk Stage II Colon Cancer Patients Treated with Adjuvant FOLFOX

Published:2014-06-03 Issue:1 Volume:22 Page:187-194
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Lee Dae-Won,Kim Kyung Ju,Han Sae-Won,Lee Hyun Jung,Rhee Ye Young,Bae Jeong Mo,Cho Nam-Yun,Lee Kyung-Hun,Kim Tae-Yong,Oh Do-Youn,Im Seock-Ah,Bang Yung-Jue,Jeong Seung-Yong,Park Kyu Joo,Park Jae-Gahb,Kang Gyeong Hoon,Kim Tae-You

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-014-3826-z.pdf

Reference33 articles.

1. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987;327(6120):293–7.

2. Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008;359:1757–65.

3. De Roock W, De Vriendt V, Normanno N, Ciardiello F, Tejpar S. KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer. Lancet Oncol. 2011;12:594–603.

4. Benson AB 3rd, Bekaii-Saab T, Chan E, et al. Metastatic colon cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11:141–52.

5. Andreyev HJ, Norman AR, Cunningham D, Oates JR, Clarke PA. Kirsten ras mutations in patients with colorectal cancer: the multicenter “RASCAL” study. J Natl Cancer Inst. 1998;90:675–84.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological features and prognosis analysis of proximal colonic mucinous adenocarcinoma;Scientific Reports;2024-08-12

2. Reclassification of RAS/BRAF allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer;Therapeutic Advances in Medical Oncology;2024-01

3. KRAS mutations and their associations with clinicopathological features and survival in Vietnamese non‑polyp colon cancer patients;Molecular and Clinical Oncology;2023-06-30

4. Associations between KRAS status and clinical features in non-polyp colon cancer patients;Asia-Pacific Journal of Oncology;2023-06-28

5. Enhancing an Oxidative “Trojan Horse” Action of Vitamin C with Arsenic Trioxide for Effective Suppression of KRAS-Mutant Cancers: A Promising Path at the Bedside;Cells;2022-11-01